In the pursuit of a healthier and more fulfilling life, exercise plays a pivotal role. Among the diverse forms of exercise, resistance training stands...
Mankind Pharma launches drug for treatment of infertility in IndiaTuesday June 2, 2020 at 3:17 pm
With the launch, the company has become the first Indian and second global firm to develop the drug, Mankind Pharma said in a statement.
Drug firm Mankind Pharma said it has launched its generic Dydrogesterone tablets for the treatment of infertility and pregnancy-related complications in the Indian market. With the launch, the company has become the first Indian and second global firm to develop the drug, Mankind Pharma said in a statement.
The company’s product is a generic version of Abbott’s Duphaston tablets, it added.
The manufacturing process of Dydrogesterone is very complex as it involves the conversion of natural progesterone, the statement said.
Progesterone is a natural hormone involved in the menstrual cycle, implantation, and in successful maintenance of pregnancy.
Any deficiency of progesterone during different stages of the reproductive process can cause infertility, menstrual disorders and miscarriage, it added.
“The launch of this drug is an important milestone for Mankind Pharma. We are the first Indian pharmaceutical company to develop this drug and second company in the world,” Mankind Group founder and Chairman R C Juneja said.